[{"NetIncomeLoss_1_Q1_USD":39926000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-17000.0,"RestrictedCashCurrent_0_Q1_USD":1735000.0,"PaymentsForRestructuring_1_Q1_USD":5640000.0,"Depreciation_1_Q1_USD":410000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":3126000.0,"AssetsCurrent_0_Q1_USD":538246000.0,"LongTermDebt_0_Q1_USD":436078000.0,"AccruedVacationCurrent_0_Q1_USD":2612000.0,"AccountsReceivableNetNoncurrent_0_Q1_USD":23563000.0,"RestructuringCharges_1_Q1_USD":311000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q1_USD":3000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":27652000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":57522000.0,"AccruedSalariesCurrent_0_Q1_USD":1408000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":2230000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":436078000.0,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":1804000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3065000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q1_USD":2390000.0,"CommonStockSharesIssued_0_Q1_shares":161931012.0,"Assets_0_Q1_USD":599344000.0,"ShareBasedCompensation_1_Q1_USD":5396000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":16279000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q1_USD":126557000.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":78476000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":-35037000.0,"OperatingLeaseLiability_0_Q1_USD":23006000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1536160000.0,"DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_0_Q1_USD":112309000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2355000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":15484000.0,"HedgingLiabilitiesNoncurrent_0_Q1_USD":7979000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":29719000.0,"EarningsPerShareBasic_1_Q1_USD":0.25,"AccruedBonusesCurrent_0_Q1_USD":3070000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":162347000.0,"AccountsReceivableNetCurrent_0_Q1_USD":87152000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":432000.0,"CommonStockValue_0_Q1_USD":162000.0,"InvestmentIncomeNet_1_Q1_USD":196000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-7942000.0,"InterestPayableCurrent_0_Q1_USD":2105000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0_Q1_USD":11346000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":4109000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2211000.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":6145000.0,"CostsAndExpenses_1_Q1_USD":43447000.0,"RestrictedCash_0_Q1_USD":2220000.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":-4109000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":39926000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":39926000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_1_Q1_USD":-1719000.0,"OtherAssetsNoncurrent_0_Q1_USD":924000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":438469000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":19862000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":-133000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"AccountsReceivableNet_0_Q1_USD":110700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":40358000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5396000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":73694000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":160967000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":3129000.0,"LiabilitiesCurrent_0_Q1_USD":23603000.0,"AccountsPayableCurrent_0_Q1_USD":842000.0,"RestructuringReserveAccrualAdjustment1_1_Q1_USD":-316000.0,"NonoperatingIncomeExpense_1_Q1_USD":-5040000.0,"InterestExpense_1_Q1_USD":7626000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":440689000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":10890000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2211000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1878000.0,"InterestExpenseDebt_1_Q1_USD":7626000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":300000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0_Q1_USD":201500000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.058,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-19000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":39926000.0,"ShortTermLeaseCost_1_Q1_USD":214000.0,"RestructuringReserveCurrent_0_Q1_USD":5475000.0,"OperatingLeasePayments_1_Q1_USD":773000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q1_USD":4500000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":8501000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q1_USD":7216000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":977000.0,"AmortizationOfFinancingCosts_1_Q1_USD":398000.0,"EarningsPerShareDiluted_1_Q1_USD":0.25,"OtherEmployeeRelatedLiabilitiesCurrent_0_Q1_USD":838000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":6713000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":3189000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1681000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":88845000.0,"OperatingIncomeLoss_1_Q1_USD":45398000.0,"RestructuringReserve_0_Q1_USD":5811000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":7979000.0,"PreferredStockValue_0_Q1_USD":null,"OperatingLeaseCost_1_Q1_USD":631000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":599344000.0,"PreferredStockSharesAuthorized_0_Q1_shares":75000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q1_USD":203750000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5396000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":5424000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3144000.0,"ProfitLoss_1_Q1_USD":39926000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1630000.0,"StockholdersEquity_0_Q1_USD":110192000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":546523000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":5822000.0,"HedgingAssetsNoncurrent_0_Q1_USD":11346000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1426130000.0,"LeaseCost_1_Q1_USD":845000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":75905000.0,"CommonStockSharesOutstanding_0_Q1_shares":161931012.0,"RestrictedCashNoncurrent_0_Q1_USD":485000.0,"EntityListingParValuePerShare_1_Q1_USD":0.001,"Ticker":"IRWD","CIK":"1446847","name":"IRONWOOD PHARMACEUTICALS INC","OfficialName":"Ironwood Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1913848067.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]